MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Archives & Legacy
* Developments: Celgene (Archives 2017)
Parents
Archives & Legacy
Developments: Celgene
Children
2017: BeiGene Presents Preliminary Phase 1 Data for BGB-A317 in Chinese Patients with Advanced Tumors at the 20th Annual Meeting of CSCO_Press Releases
2017: Biotech Forum Daily Digest - Celgene Continues To Make Deals, Spotlight On Xenon
2017: bluebird bio Announces First Patient Treated with Second Anti-BCMA CAR T bb21217 in CRB-402 Phase 1 Study in Patients with Relapsed/Refractory Multiple Myeloma
2017: Celgene As Another Amazon.com: Buying The Dips - Celgene Corporation (NASDAQ:CELG)
2017: Celgene cans phase 3 trial of $710M Crohn’s drug GED-0301
2017: Celgene Crashes: A Reassessment - Celgene Corporation (NASDAQ:CELG)
2017: Celgene Looks Cheap Right Now - Celgene Corporation (NASDAQ:CELG)
2017: Celgene Takes A Deserved Hit On Major Phase 3 Failure_seekingalpha
2017: Celgene: A Core Biotech Holding For 2017 And Beyond - Celgene Corporation (NASDAQ:CELG)
2017: The Case For Celgene - Celgene Corporation (NASDAQ:CELG)
2017: What Gilead Could Learn From Celgene - Gilead Sciences, Inc. (NASDAQ:GILD)